ВОСПАЛИТЕЛЬНЫЕ ИЗМЕНЕНИЯ ДЕСЕН И СЛИЗИСТОЙ ОБОЛОЧКИ ПОЛОСТИ РТА ПРИ БОЛЕЗНИ КРОНА ПО ДАННЫМ ГОДИЧНОГО КЛИНИЧЕСКОГО НАБЛЮДЕНИЯ
DOI:
https://doi.org/10.5281/zenodo.24245208Keywords:
Crohn’s disease, extraintestinal manifestations, oral mucosa, gingivitis, oral ulcers, periodontium, clinical observationAbstract
Background. Extraintestinal manifestations of Crohn’s disease affect various anatomical regions, including the oral mucosa and periodontal tissues. Their identification is complicated by morphological heterogeneity, concomitant dental diseases, deficiency states, and the effects of pharmacological therapy. Objective. To characterize the frequency of documented inflammatory gingival changes and ulcerative lesions of the oral mucosa in patients with Crohn’s disease based on data from a one-year clinical observation period. Materials and Methods. A single-center descriptive analysis was conducted using data from 52 patients observed in the Therapeutic Department of the Shofirkon District Medical Association. The duration of Crohn’s disease ranged from 3 to 5 years. The primary outcome was a combined category defined as “gingival lesions and oral ulcers.” Results were presented as absolute numbers and proportions, and a 95% confidence interval for the primary proportion was calculated using the Wilson method. Results. Changes within the combined category were documented in 18 of 52 patients (34.6%), while the corresponding findings were not recorded in the available data for the remaining 34 patients (65.4%). Eight patients (15.4%) were aged 18–22 years, 14 (26.9%) were aged 23–35 years, and 30 (57.7%) were older than 35 years. In selected clinical observations, ulcer healing was described during systemic hormonal therapy. Positive clinical changes were also observed during local oral care involving lysozyme; however, the exact number of patients receiving this intervention, response criteria, and assessment time points were not reported. Conclusion. The findings emphasize the importance of systematic oral examination in patients with Crohn’s disease. However, the available data do not allow determination of the frequency of individual morphological manifestations or assessment of lysozyme efficacy. Future studies should incorporate standardized dental examinations, assessment of intestinal inflammatory activity, and prospective documentation of clinical outcomes.References
1. Gordon H., Burisch J., Ellul P., et al. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. Journal of Crohn’s and Colitis. 2024;18(1):1–37. https://doi.org/10.1093/ecco-jcc/jjad108.
2. Lauritano D., Boccalari E., Di Stasio D., et al. Prevalence of Oral Lesions and Correlation with Intestinal Symptoms of Inflammatory Bowel Disease: A Systematic Review. Diagnostics. 2019;9(3):77. https://doi. org/10.3390/diagnostics9030077.
3. Papageorgiou S.N., Hagner M., Nogueira A.V.B., et al. Inflammatory bowel disease and oral health: systematic review and a meta-analysis. Journal of Clinical Periodontology. 2017;44(4):382–393. https:// doi.org/10.1111/jcpe.12698.
4. Domokos Z., Uhrin E., Szabó B., et al. Patients with inflammatory bowel disease have a higher chance of developing periodontitis: A systematic review and meta-analysis. Frontiers in Medicine. 2022;9:1020126. https://doi.org/10.3389/fmed.2022.1020126.
5. Pecci-Lloret M.P., Ramirez-Santisteban E., Hergueta-Castillo A., Guerrero-Gironés J., Oñate-Sánchez R.E. Oral Manifestations of Crohn’s Disease: A Systematic Review. Journal of Clinical Medicine. 2023;12(20):6450. https://doi.org/10.3390/jcm12206450.
6. Cagir Y., Durak M.B., Simsek C., Yuksel I. Specific Oral Manifestations in Adults with Crohn’s Disease. Journal of Clinical Medicine. 2024;13(13):3955. https://doi.org/10.3390/jcm13133955.
7. Harty S., Fleming P., Rowland M., et al. A prospective study of the oral manifestations of Crohn’s disease. Clinical Gastroenterology and Hepatology. 2005;3(9):886–891. https://doi.org/10.1016/S1542-3565(05)00424-6.
8. Plauth M., Jenss H., Meyle J. Oral manifestations of Crohn’s disease. An analysis of 79 cases. Journal of Clinical Gastroenterology. 1991;13(1):29–37. https://doi.org/10.1097/00004836-199102000-00008.
9. Scheper H.J., Brand H.S. Oral aspects of Crohn’s disease. International Dental Journal. 2002;52(3):163–172. https://doi.org/10.1111/j.1875-595X.2002.tb00622.x.
10. Lankarani K.B., Sivandzadeh G.R., Hassanpour S. Oral manifestation in inflammatory bowel disease: a review. World Journal of Gastroenterology. 2013;19(46):8571–8579. https://doi.org/10.3748/wjg.v19. i46.8571.
11. Gordon H., Minozzi S., Kopylov U., et al. ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment. Journal of Crohn’s and Colitis. 2024;18(10):1531–1555. https://doi.org/10.1093/ecco-jcc/ jjae091.
12. Lichtenstein G.R., Loftus E.V., Afzali A., et al. ACG Clinical Guideline: Management of Crohn’s Disease in Adults. American Journal of Gastroenterology. 2025;120(6):1225–1264. https://doi.org/10.14309/ ajg.0000000000003465.

